Cargando…
A New Approach to the Development of Disease‐Modifying Therapies for PD; Fighting Another Pandemic
A disease‐modifying therapy that slows disease progression and development of disability is the major unmet need in the treatment of Parkinson's disease. Recent scientific advances suggest many promising and exciting new interventions. However, despite these opportunities, the cost, time and un...
Autores principales: | Kieburtz, Karl, Katz, Russell, McGarry, Andrew, Olanow, C. Warren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891378/ https://www.ncbi.nlm.nih.gov/pubmed/33026697 http://dx.doi.org/10.1002/mds.28310 |
Ejemplares similares
-
Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study
por: McGarry, Andrew, et al.
Publicado: (2020) -
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity
por: Werner, Milton H., et al.
Publicado: (2021) -
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study
por: Poewe, Werner, et al.
Publicado: (2021) -
Another name for autotaxin
por: Dove, Alan W.
Publicado: (2002) -
Fungus-fighting vaccine
por: Johnston, Nicole
Publicado: (2005)